Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rrAD: Exercise and Vascular Risk Reduction for Dementia Prevention
NCT02913664Phase 3Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2017
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of losartan, amlodipine and atorvastatin in Alzheimer's disease (AD), vascular dementia, hypertension (HTN) and 1 more, sponsored by UT Southwestern Medical Center. Started Feb 2017; status: completed.
02
Drugs
losartanamlodipineatorvastatin
03
Conditions
Alzheimer's disease (AD)vascular dementiahypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT02913664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02913664.